Arrowstreet Capital’s CareDx CDNA Stock Holding History

Arrowstreet Capital’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$134M	Buy	2,059,397 +1,687,286	+453%	+$76.5M	0.06%	296
2026 Q2	$10.6M	Buy	+372,111	New	+$8.1M	﹤0.01%	1059
2025 Q2	–	Sell	-38,580	Closed	-$685K	–	1938
2025 Q1	$685K	Buy	38,580 +4,418	+13%	+$95.2K	﹤0.01%	1567
2024 Q4	$731K	Buy	+34,162	New	+$831K	﹤0.01%	1521
2024 Q2	–	Sell	-216,891	Closed	-$2.3M	–	1546
2024 Q1	$2.3M	Sell	216,891 -129,006	-37%	-$1.29M	﹤0.01%	1102
2023 Q4	$4.15M	Buy	+345,897	New	+$2.83M	﹤0.01%	803
2021 Q4	–	Sell	-11,900	Closed	-$754K	–	1465
2021 Q3	$754K	Sell	11,900 -12,600	-51%	-$960K	﹤0.01%	1352
2021 Q2	$2.24M	Buy	24,500 +16,600	+210%	+$1.32M	﹤0.01%	1313
2021 Q1	$538K	Buy	+7,900	New	+$613K	﹤0.01%	1976
2020 Q4	–	Sell	-20,724	Closed	-$786K	–	2304
2020 Q3	$786K	Buy	+20,724	New	+$700K	﹤0.01%	1884

Other funds holding CDNA

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Blue Water Life Science Advisors Larkspur, California $252M AUM 302.2% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $40.4B AUM 35.78% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Arrowstreet Capital's CDNA Position: Q3 2026 in Review

Arrowstreet Capital increased its CareDx (CDNA) stake by 453% in Q3 2026, buying an estimated $76.5M and bringing the position to 2,059,397 shares worth $134M. The position accounts for 0.06% of the portfolio, ranked #296.

Arrowstreet Capital first reported a position in CDNA in Q3 2020 and has held it in 10 quarters since. 221 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

Arrowstreet Capital held 2,059,397 shares of CareDx worth $134M as of Q3 2026.
Arrowstreet Capital bought 1,687,286 CareDx shares in Q3 2026, an estimated $76.5M.
CareDx made up 0.06% of Arrowstreet Capital's portfolio in Q3 2026, its #296 holding.
Arrowstreet Capital first reported a position in CareDx in Q3 2020 and has held it in 10 quarters since.
221 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Arrowstreet Capital's 13F filing for Q3 2026, filed 13 Nov 2026.